Peritoneal dialysis related peritonitis: insights from a long-term analysis of an Italian center

• Published in: BMC nephrology Vol. 25; no. 1; p. 163
• Main Authors: Nardelli, Luca, Scalamogna, Antonio, Ponzano, Federico, Sikharulidze, Anna, Tripodi, Federica, Vettoretti, Simone, Alfieri, Carlo, Castellano, Giuseppe
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 11-05-2024; BioMed Central; BMC
• Subjects: Adult; Aged; Antibiotics; Automation; Catheter; Catheters; Causes of; Comparative analysis; Complications and side effects; Continuous ambulatory peritoneal dialysis; Ethics; Female; HD transfer; Health aspects; Hemodialysis; Hospitalization; Humans; Infections; Italy - epidemiology; Kidney Failure, Chronic - therapy; Male; Medical research; Medicine, Experimental; Middle Aged; Mortality; Patient outcomes; Patients; Peritoneal dialysis; Peritoneal Dialysis - adverse effects; Peritoneum; Peritonitis; Peritonitis - epidemiology; Peritonitis - etiology; Retrospective Studies; Statistics; Variables; Italy; United States > US; Catheter; Hospitalization; HD transfer; Mortality; Peritoneal dialysis; Peritonitis
• ISSN: 1471-2369; 1471-2369
• DOI: 10.1186/s12882-024-03594-y

Peritonitis is a common and severe complication of peritoneal dialysis (PD). For comparative analysis standardized definitions as well as measurements and outcomes are crucial. However, most PD-related peritonitis studies have been using heterogenous definitions and variable methods to measure outcomes. The ISPD 2022 guidelines have revised and clarified numerous definitions and proposed new peritonitis categories and outcomes.
Between 1st January 2009 and 31st May 2023, 267 patients who started PD at our institution were included in the study. All PD-related peritonitis episodes that occurred in our unit during the study period were collected. The new definitions and outcomes of ISPD 2022 recommendations were employed.
The overall peritonitis rate was 0.25 episode/patient year. Patient cumulative probability of remaining peritonitis-free at one year was 84.2%. The medical cure and refractory peritonitis rates were equal to 70.3 and 22.4%, respectively. Culture-negative peritonitis accounted for 25.6% of all specimens. The rates of peritonitis associated death, hemodialysis transfer, catheter removal and hospitalization were 6.8%, 18.3%, 18.7% and 64.4%, respectively. Relapsing, repeat, recurrent and enteric peritonitis accounted for 7.8%, 6.8%, 4.1% and 2.7% of all episodes, respectively. Catheter insertion, catheter related and pre-PD peritonitis were 4.2, 2.1 and 0.5%.
The implementation of PD-related peritonitis reports using standardized definitions and outcome measurements is of paramount importance to enhance clinical practice and to allow comparative studies.